<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/483362</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;483362v3</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;483362</article-id><article-id pub-id-type="other" hwp:sub-type="slug">483362</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">483362</article-id><article-id pub-id-type="other" hwp:sub-type="tag">483362</article-id><article-version>1.3</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Genetics" hwp:journal="biorxiv"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Somatic uniparental disomy mitigates the most damaging <italic toggle="yes">EFL1</italic> allele combination in Schwachman-Diamond syndrome</article-title></title-group><author-notes hwp:id="author-notes-1"><fn id="n1" fn-type="equal" hwp:id="fn-1" hwp:rev-id="xref-fn-1-1 xref-fn-1-2"><label>*</label><p hwp:id="p-1">S. Lee, and C.H. Shin contributed equally to this paper.</p></fn><fn id="n2" fn-type="equal" hwp:id="fn-2" hwp:rev-id="xref-fn-2-1 xref-fn-2-2 xref-fn-2-3"><label>**</label><p hwp:id="p-2">H.J. Kang, H.H.Kim, and M.Choi contributed equally to this paper</p></fn><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1 xref-corresp-1-2 xref-corresp-1-3"><label>+</label>Correspondence to Murim Choi: <email hwp:id="email-1">murimchoi@snu.ac.kr</email>; or Hyeon Ho Kim: <email hwp:id="email-2">hyeonhkim@skku.edu</email> or Hyoung Jin Kang: <email hwp:id="email-3">kanghj@snu.ac.kr</email></corresp><fn id="n3" fn-type="present-address" hwp:id="fn-3" hwp:rev-id="xref-fn-3-1 xref-fn-3-2"><label>15</label><p hwp:id="p-3">Sangmoon Lee (Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA). Chang Hoon Shin (Laboratory of Genetics and Genomics, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA).</p></fn></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Lee Sangmoon"><surname>Lee</surname><given-names>Sangmoon</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-1" hwp:rel-id="fn-1">*</xref><xref ref-type="fn" rid="n3" hwp:id="xref-fn-3-1" hwp:rel-id="fn-3">15</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Shin Chang Hoon"><surname>Shin</surname><given-names>Chang Hoon</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-2" hwp:rel-id="fn-1">*</xref><xref ref-type="fn" rid="n3" hwp:id="xref-fn-3-2" hwp:rel-id="fn-3">15</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Lee Jawon"><surname>Lee</surname><given-names>Jawon</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Jeong Seong Dong"><surname>Jeong</surname><given-names>Seong Dong</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Hong Che Ry"><surname>Hong</surname><given-names>Che Ry</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Kim Jun-Dae"><surname>Kim</surname><given-names>Jun-Dae</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Kim Ah-Ra"><surname>Kim</surname><given-names>Ah-Ra</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="Son Soo Jin"><surname>Son</surname><given-names>Soo Jin</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-1" hwp:rel-id="aff-6">6</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-1" hwp:rel-id="aff-7">7</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Kokhan Oleksandr"><surname>Kokhan</surname><given-names>Oleksandr</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-1" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-10"><name name-style="western" hwp:sortable="Yoo Taekyeong"><surname>Yoo</surname><given-names>Taekyeong</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-11"><name name-style="western" hwp:sortable="Ko Jae Sung"><surname>Ko</surname><given-names>Jae Sung</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-12"><name name-style="western" hwp:sortable="Sohn Young Bae"><surname>Sohn</surname><given-names>Young Bae</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-1" hwp:rel-id="aff-9">9</xref></contrib><contrib contrib-type="author" hwp:id="contrib-13"><name name-style="western" hwp:sortable="Kim Ok-Hwa"><surname>Kim</surname><given-names>Ok-Hwa</given-names></name><xref ref-type="aff" rid="a10" hwp:id="xref-aff-10-1" hwp:rel-id="aff-10">10</xref></contrib><contrib contrib-type="author" hwp:id="contrib-14"><name name-style="western" hwp:sortable="Ko Jung Min"><surname>Ko</surname><given-names>Jung Min</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-3" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-15"><name name-style="western" hwp:sortable="Cho Tae-Joon"><surname>Cho</surname><given-names>Tae-Joon</given-names></name><xref ref-type="aff" rid="a11" hwp:id="xref-aff-11-1" hwp:rel-id="aff-11">11</xref></contrib><contrib contrib-type="author" hwp:id="contrib-16"><name name-style="western" hwp:sortable="Wright Nathan T."><surname>Wright</surname><given-names>Nathan T.</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-2" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-17"><name name-style="western" hwp:sortable="Seong Je Kyung"><surname>Seong</surname><given-names>Je Kyung</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-2" hwp:rel-id="aff-6">6</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-2" hwp:rel-id="aff-7">7</xref><xref ref-type="aff" rid="a12" hwp:id="xref-aff-12-1" hwp:rel-id="aff-12">12</xref></contrib><contrib contrib-type="author" hwp:id="contrib-18"><name name-style="western" hwp:sortable="Jin Suk-Won"><surname>Jin</surname><given-names>Suk-Won</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-2" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-2" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-19"><name name-style="western" hwp:sortable="Kang Hyoung Jin"><surname>Kang</surname><given-names>Hyoung Jin</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-4" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-1" hwp:rel-id="aff-13">13</xref><xref ref-type="fn" rid="n2" hwp:id="xref-fn-2-1" hwp:rel-id="fn-2">**</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">+</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-20"><name name-style="western" hwp:sortable="Kim Hyeon Ho"><surname>Kim</surname><given-names>Hyeon Ho</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-3" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-1" hwp:rel-id="aff-14">14</xref><xref ref-type="fn" rid="n2" hwp:id="xref-fn-2-2" hwp:rel-id="fn-2">**</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-2" hwp:rel-id="corresp-1">+</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-21"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9195-1455</contrib-id><name name-style="western" hwp:sortable="Choi Murim"><surname>Choi</surname><given-names>Murim</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-4" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-5" hwp:rel-id="aff-3">3</xref><xref ref-type="fn" rid="n2" hwp:id="xref-fn-2-3" hwp:rel-id="fn-2">**</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-3" hwp:rel-id="corresp-1">+</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-9195-1455"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3 xref-aff-1-4"><label>1</label><institution hwp:id="institution-1">Department of Biomedical Sciences, Seoul National University College of Medicine</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2 xref-aff-2-3"><label>2</label><institution hwp:id="institution-2">Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2 xref-aff-3-3 xref-aff-3-4 xref-aff-3-5"><label>3</label><institution hwp:id="institution-3">Department of Pediatrics, Seoul National University College of Medicine</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1 xref-aff-4-2"><label>4</label><institution hwp:id="institution-4">Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine</institution>, New Haven, CT, <country>USA</country></aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1 xref-aff-5-2"><label>5</label><institution hwp:id="institution-5">School of Life Sciences, Gwangju Institute of Science and Technology</institution>, Gwangju, <country>Republic of Korea</country></aff><aff id="a6" hwp:id="aff-6" hwp:rev-id="xref-aff-6-1 xref-aff-6-2"><label>6</label><institution hwp:id="institution-6">Laboratory of Developmental Biology and Genomics, Research Institute for Veterinary Science, and BK21 PLUS Program for Creative Veterinary Science Research, College of Veterinary Medicine, Seoul National University</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a7" hwp:id="aff-7" hwp:rev-id="xref-aff-7-1 xref-aff-7-2"><label>7</label><institution hwp:id="institution-7">Korea Mouse Phenotyping Center (KMPC), Seoul National University</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a8" hwp:id="aff-8" hwp:rev-id="xref-aff-8-1 xref-aff-8-2"><label>8</label><institution hwp:id="institution-8">Department of Chemistry and Biochemistry, James Madison University</institution>, Harrisonburg, VA, <country>USA</country></aff><aff id="a9" hwp:id="aff-9" hwp:rev-id="xref-aff-9-1"><label>9</label><institution hwp:id="institution-9">Department of Medical Genetics, Ajou University Hospital, Ajou University School of Medicine</institution>, Suwon, <country>Republic of Korea</country></aff><aff id="a10" hwp:id="aff-10" hwp:rev-id="xref-aff-10-1"><label>10</label><institution hwp:id="institution-10">Department of Radiology, Woorisoa Children’s Hospital</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a11" hwp:id="aff-11" hwp:rev-id="xref-aff-11-1"><label>11</label><institution hwp:id="institution-11">Department of Orthopaedic Surgery, Seoul National University College of Medicine</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a12" hwp:id="aff-12" hwp:rev-id="xref-aff-12-1"><label>12</label><institution hwp:id="institution-12">Interdisciplinary Program for Bioinformatics, Program for Cancer Biology and BIO-MAX/N-Bio Institute, Seoul National University</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a13" hwp:id="aff-13" hwp:rev-id="xref-aff-13-1"><label>13</label><institution hwp:id="institution-13">Seoul National University Cancer Research Institute</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a14" hwp:id="aff-14" hwp:rev-id="xref-aff-14-1"><label>14</label><institution hwp:id="institution-14">Institute for Future Medicine, Samsung Medical Center</institution>, Seoul, <country>Republic of Korea</country></aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-12-04T07:39:09-08:00">
    <day>4</day><month>12</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-01-12T00:27:16-08:00">
    <day>12</day><month>1</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-12-04T07:45:58-08:00">
    <day>4</day><month>12</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-01-12T00:30:28-08:00">
    <day>12</day><month>1</month><year>2021</year>
  </pub-date><elocation-id>483362</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-11-29"><day>29</day><month>11</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2021-01-11"><day>11</day><month>1</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-01-11"><day>11</day><month>1</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="license-1"><p hwp:id="p-4">This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></p></license></permissions><self-uri xlink:href="483362.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/483362v3.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="483362.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/483362v3/483362v3.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/483362v3/483362v3.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-5">Shwachman-Diamond syndrome (SDS; OMIM: #260400) is caused by variants in <italic toggle="yes">SBDS</italic> (Shwachman-Bodian-Diamond syndrome gene), which encodes a protein that plays an important role in ribosome assembly. Recent reports suggest that recessive variants in <italic toggle="yes">EFL1</italic> are also responsible for SDS. However, the precise genetic mechanism that leads to <italic toggle="yes">EFL1</italic>-induced SDS remains incompletely understood. Here we present three unrelated Korean SDS patients that carry biallelic pathogenic variants in <italic toggle="yes">EFL1</italic> with biased allele frequencies, resulting from a bone marrow-specific somatic uniparental disomy (UPD) in chromosome 15. The recombination events generated cells that were homozygous for the relatively milder variant, allowing for the evasion of catastrophic physiological consequences. Still, the milder <italic toggle="yes">EFL1</italic> variant was solely able to impair 80S ribosome assembly and induce SDS features in cell line, zebrafish, and mouse models. The loss of <italic toggle="yes">EFL1</italic> resulted in a pronounced inhibition of terminal oligo-pyrimidine element-containing ribosomal protein transcript 80S assembly. Therefore, we propose a more accurate pathogenesis mechanism of EFL1 dysfunction that eventually leads to aberrant translational control and ribosomopathy.</p></abstract><counts><page-count count="38"/></counts><custom-meta-wrap><custom-meta hwp:id="custom-meta-1"><meta-name>special-property</meta-name><meta-value>contains-inline-supplementary-material</meta-value></custom-meta></custom-meta-wrap><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-2">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-2">Competing Interest Statement</title><p hwp:id="p-6">The authors have declared no competing interest.</p></notes></notes></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-3">Introduction</title><p hwp:id="p-7">Patients clinically diagnosed with Shwachman-Diamond syndrome (SDS; OMIM: #260400) present with a constellation of disorders, such as hematologic manifestations, exocrine pancreatic dysfunction with fatty infiltration, and skeletal dysplasia that results in short stature<sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>-<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref></sup>. The hematologic manifestations include neutropenia or, less severely, thrombocytopenia and anemia with a predisposition for myelodysplastic syndrome and acute myeloid leukemia transformations<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>,<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref></sup>. Variants in <italic toggle="yes">SBDS</italic> (Shwachman-Bodian-Diamond syndrome gene), which encodes a protein that plays an important role in ribosome assembly, are mainly responsible for the disease<sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-2" hwp:rel-id="ref-1">1</xref>,<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref>-<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref></sup>. Thus, SDS is considered to be a ribosomopathy, which is a collective term that is used to describe a group of congenital disorders caused by problems in ribosome biogenesis, assembly or function<sup><xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref></sup>.</p><p hwp:id="p-8">Moreover, ∼10% of clinically diagnosed SDS cases do not contain any pathogenic <italic toggle="yes">SBDS</italic> variants, suggesting the existence of additional genetic mechanisms that lead to the disorder<sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-3" hwp:rel-id="ref-1">1</xref>,<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-2" hwp:rel-id="ref-6">6</xref></sup>. Recent reports demonstrate that variants in genes other than <italic toggle="yes">SBDS</italic>, namely <italic toggle="yes">EFL1, DNAJC21</italic>, and <italic toggle="yes">SRP54</italic>, are implicated with bone marrow failure syndrome and SDS<sup><xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>-<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref></sup>.</p><p hwp:id="p-9">Homozygous variants of <italic toggle="yes">EFL1</italic> cause an SDS-like syndrome in a recessive manner, which is highlighted by the observation that three of the seven reported kindreds underwent consanguineous marriages<sup><xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">10</xref>,<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>,<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-2" hwp:rel-id="ref-15">15</xref></sup>. EFL1 directly interacts with SBDS to release eukaryotic translation initiation factor 6 (eIF6) from the 60S ribosomal subunit for 80S ribosomal assembly<sup><xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>,<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref></sup>. Thus, it needs to be further investigated whether there is an additional genetic mechanism that leads to SDS in outbred populations other than through homozygous pathogenic variants in <italic toggle="yes">EFL1</italic>.</p><p hwp:id="p-10">As more human genomes with or without clinical significances continue to be sequenced, it has become clear that variants of unknown significances (VUS) pose a substantial obstacle in the interpretation of genotype-phenotype relationships. As many variants are believed to possess the ability to cause alternations at the molecular level but only with sub-clinical levels of severity, numerous scenarios that enable VUS to acquire clinical significances have been postulated. One of these scenarios involves the assessment of somatically acquired uniparental disomy (UPD) in the hematopoietic system; although only a small number of instances have been previously reported. Notable examples include myeloid neoplasia<sup><xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>,<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref></sup>, immunodeficiency<sup><xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref></sup>, and a single case of sickle cell disease<sup><xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref></sup>.</p><p hwp:id="p-11">In this study, we demonstrated a disease-causing mechanism in patients who inherited compound heterozygous variants in <italic toggle="yes">EFL1</italic>. A mosaic UPD caused a loss-of-heterozygosity (LOH) in the <italic toggle="yes">EFL1</italic> locus in the bone marrow and blood, simultaneously homozygosing the less damaging variant and decreasing the representation of the more damaging variant to avoid worse hematologic phenotypes. However, this still led to EFL1 dysfunction in the bone marrow and resulted in SDS features. We further demonstrated that the remaining variant by the UPD was a hypomorph and pathogenic, by investigating the molecular mechanism of the EFL1 dysfunction in cell and animal models. Therefore, searching for a pathogenic variant that was caused by a non-conventional pathway may increase the probability of identifying the genetic cause and improve our understanding of the disease mechanism, and this approach could possibly benefit additional patients with severe hematological abnormalities.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-4">Results</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-5">Shwachman-Diamond syndrome patients without <italic toggle="yes">SBDS</italic> variants</title><p hwp:id="p-12">We recruited three unrelated and non-consanguineous Korean SDS patients without plausible recessive mutations in <italic toggle="yes">SBDS</italic> (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig. 1a</xref>; Table S1; Supplemental Clinical Narratives). Proband I-1 is a 3-year-old boy who had severe intrauterine growth retardation that resulted in a preterm delivery (35+3 weeks) and a birth weight of 1.7 kg. He had thrombocytopenia, neutropenia, and anemia at 2-months of age. A bone marrow examination performed at 6-months of age revealed hypocellularity, reduced megakaryocytes, and an increase in iron storage. He also had pancreatic lipomatosis, along with an exocrine pancreatic insufficiency, and metaphyseal chondrodysplasia (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Fig. 1a</xref>; Fig. S1). Proband II-1 is a 9-year-old female who had severe intrauterine growth retardation that resulted in a preterm delivery (36 weeks) and a birth weight of 1.6 kg. She had a diffuse fatty infiltration of the pancreas and metaphyseal chondrodysplasia that was accompanied by osteopenia and short stature (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Fig. 1a</xref>). Her sister was unaffected. Proband III-1 is a 25-year-old male who did not have any perinatal problems except for a low birth weight (40+4 weeks, 2.4 kg). At 2-years-old, he had pancreatic exocrine and endocrine insufficiencies, thrombocytopenia, anemia, intermittent neutropenia, metaphyseal chondrodysplasia, and ichthyosis. Later, he developed osteoporosis, hepatomegaly, and a total fatty change of the pancreas (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Fig. 1a</xref>).</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7 xref-fig-1-8 xref-fig-1-9 xref-fig-1-10 xref-fig-1-11"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;483362v3/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Fig. 1.</label><caption hwp:id="caption-1"><title hwp:id="title-6"><italic toggle="yes">EFL1</italic> variants in <italic toggle="yes">SBDS</italic>-negative SDS patients.</title><p hwp:id="p-13"><bold>a</bold> Non-contrast T1-weighted abdominal MRI (turbo spin echo) or CT images showing a diffuse enlargement with lipomatosis of the pancreas (arrows) (upper) and X-ray images of both knees showing bilateral metaphyseal widening of the femurs (I-1) or irregularity and genu varum (III-1) in the three patients (lower). <bold>b-d</bold> Pedigrees and Sanger sequencing traces showing the inherited <italic toggle="yes">EFL1</italic> variants and the <italic toggle="yes">de novo SBDS</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Asp110Asn</italic></sup> variant in the three families. DNA was extracted from whole blood samples. Note that the lower case nucleotide letters were used on top of the Sanger traces to reflect their minor representation in the patient samples. <bold>e</bold> The residues with nonsynonymous changes in EFL1 and SBDS are evolutionarily conserved. The arrowheads on the protein maps denote previously reported pathogenic variants (Blue: missense, red: LoF). <bold>f</bold> Molecular modeling-based structural analysis using PDB 5ANC<sup><xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">7</xref></sup>. The insets show the detailed interactions involving EFL1 His30, Thr1069 and SBDS Asp110. B.t., <italic toggle="yes">Bos taurus</italic>; C.i., <italic toggle="yes">Ciona intestinalis</italic>; D.m., <italic toggle="yes">Drosophila melanogaster</italic>; D.r., <italic toggle="yes">Danio rerio</italic>; G.g., <italic toggle="yes">Gallus gallus</italic>; H.s., <italic toggle="yes">Homo sapiens</italic>; M.m., <italic toggle="yes">Mus musculus</italic>; O.c., <italic toggle="yes">Oryctolagus cuniculus</italic>.</p></caption><graphic xlink:href="483362v3_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-7">Identification of mosaic <italic toggle="yes">EFL1</italic> variants</title><p hwp:id="p-14">To identify the genetic factors that predisposed the three patients to SDS, we exome-sequenced the patients and the available parental DNA was extracted from whole blood (Table S2). Notably, the heterozygous p.Thr1069Ala variant of <italic toggle="yes">EFL1</italic> (chr15:82,422,872 T&gt;C, hg19, NM_024580.5:c.3205A&gt;G) was identified in all three patients (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Fig. 1b-d</xref>, <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref>; Table S3), which was not previously found in SDS patients. Based on gnomAD, it is a low frequency variant that was carried by three individuals among 17,972 alleles in the East Asian population (East Asian allele frequency (EA-AF) = 1.7 × 10<sup>−4</sup>)<sup><xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref></sup>. Under the assumption that <italic toggle="yes">EFL1</italic> variants function in a recessive manner, we sought to ascertain additional variants that may pose increased damage to the gene function. Remarkably, we found a second variants in <italic toggle="yes">EFL1</italic> in all three patients which were not detected by the initial analysis either due to a low number of variant supporting reads in the proband or due to a low mapping quality caused by the sequence similarity between the <italic toggle="yes">EFL1</italic> and <italic toggle="yes">EFL1P1</italic> loci. Proband I-1 carried a paternally-originated frameshift variant p.Gly827TrpfsTer13 (chr15:82,444,316 C&gt;CA, hg19, NM_024580.5:c.2478dupT, gnomAD EA-AF = 0) with a minor allele frequency (MAF) of 8.3%, and Proband II-1 and III-1 carried an inherited missense variant p.His30Arg (chr15: 82,554,031 T&gt;C, hg19, NM_024580.5:c.89A&gt;G, gnomAD EA-AF = 5.1 × 10<sup>−5</sup>) with MAFs of 14.8% and 36.8%, respectively (<xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref>). In addition, Proband III-1 harbored a heterozygous <italic toggle="yes">SBDS</italic> p.Asn110Asp variant as <italic toggle="yes">de novo</italic> (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-6" hwp:rel-id="F1">Fig. 1d</xref>; Fig. S2), which is never seen in the control databases. Then we noted that the non-reference allele of <italic toggle="yes">EFL1</italic> p.Thr1069Ala for I-1 and II-1 was dominantly covered compared to the reference allele (<xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-3" hwp:rel-id="T1">Table 1</xref>), which caused it to function like an incomplete homozygous variant, while the ratio was comparable in III-1 (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Fig. 1c</xref>; <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-4" hwp:rel-id="T1">Table 1</xref>). All the <italic toggle="yes">EFL1</italic> variants were equally represented in the parental carriers. The patients did not carry any variant in other SDS-associated genes, including <italic toggle="yes">DNAJC21</italic> and <italic toggle="yes">SRP54</italic> (data not shown). The two EFL1 amino acid residues harboring the missense variants (His30 and Thr1069) are highly conserved throughout evolution and are predicted to be pathogenic (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-8" hwp:rel-id="F1">Fig. 1e</xref>; Table S4). The protein structure analysis suggested that the His30 and Thr1069 residues form hydrogen bonds with neighboring residues, which would presumably confer stability to the protein structure. Notably, previously reported pathogenic residues Cys883 and Arg970 lie close to Thr1069 (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-9" hwp:rel-id="F1">Fig. 1f</xref>; Fig. S3)<sup><xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-3" hwp:rel-id="ref-15">15</xref></sup>. The SBDS Asn110 reside is also conserved among the vertebrate species (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-10" hwp:rel-id="F1">Fig. 1e</xref>; Table S4) and is expected to interact with neighboring amino acids, including Lys151 (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-11" hwp:rel-id="F1">Fig. 1f</xref>).</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2 xref-table-wrap-1-3 xref-table-wrap-1-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;483362v3/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-2"><p hwp:id="p-15">Coverage depths and allele frequencies of <italic toggle="yes">EFL1</italic> variants</p></caption><graphic xlink:href="483362v3_tbl1" position="float" orientation="portrait" hwp:id="graphic-2"/></table-wrap><p hwp:id="p-16">To understand the genetic cause of this observation, we investigated whether large-scale structural variants exist that encompass the region. Indeed, all the patients carried a partial LOH in chromosome 15, where <italic toggle="yes">EFL1</italic> resides (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig. 2a</xref>; Figs. S4 and S5). This LOH was copy-neutral and was not seen in the healthy parents (Fig. S6), suggesting that it was caused by a somatic UPD. This LOH of the <italic toggle="yes">EFL1</italic> locus is not frequently found in healthy Korean individuals (1/3,667 = 2.7 × 10<sup>−4</sup>, Fig. S7). Also, according to a survey of hematopoietic chromosomal mosaicism events, 117 of 151,202 apparently normal individuals carry a copy-neutral LOH or a copy-number deletion of the <italic toggle="yes">EFL1</italic> locus (7.7 × 10<sup>−4</sup>)<sup><xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref></sup>. Thus, the LOH of the <italic toggle="yes">EFL1</italic> locus is a rare event. The sizes of the LOH intervals were variable among the patients (100%, 100% and 27.8% of the entire chromosome span, respectively; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Fig. 2a</xref>). We also sought to identify the haplotype origins of the variants that the probands carried and observed that the chromosomes that were dominantly represented (<italic toggle="yes">i</italic>.<italic toggle="yes">e</italic>., the maternal chromosome for I-1 and the paternal chromosome for III-1) harbored <italic toggle="yes">EFL1</italic><sup>p.Thr1069Ala</sup>, which was consistent with their higher coverage ratios compared to other variants as documented in the WES analysis (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Fig. 2a</xref>). To test if the UPD event occurred in a mosaic pattern and whether LOH-carrying and non-LOH-carrying cells co-exist, a single-cell SNP microarray experiment was performed using bone marrow (I-1) or epithelial cells from buccal swabs (III-1). As expected, complete LOHs in chromosome 15 were observed in a subset of the cells, confirming the mosaic UPD events that preferentially selected <italic toggle="yes">EFL1</italic><sup>p.Thr1069Ala</sup> over the other variants (<italic toggle="yes">i</italic>.<italic toggle="yes">e</italic>., <italic toggle="yes">EFL1</italic><sup>p.Gly827TrpfsTer13</sup> and <italic toggle="yes">EFL1</italic><sup>p.His30Arg</sup>; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Fig. 2b-d</xref>; Fig. S8). Therefore, cells containing UPD of chromosome 15 are expected to be homozygous for the <italic toggle="yes">EFL1</italic><sup>p.Thr1069Ala</sup> allele and be a homozygous reference for the other two alleles. II-1 was not tested, because the sample was unavailable. Next, we checked the spatial extent of the mosaic UPD by subjecting all available tissue samples from I-1 to a high-depth amplicon sequencing analysis (&gt;10,000X coverage depths). Variant AFs of p.Thr1069Ala in I-1 were ∼0.85 in the peripheral blood and bone marrow but ∼0.5 in most tissues.</p><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5 xref-fig-2-6 xref-fig-2-7"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;483362v3/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Fig. 2.</label><caption hwp:id="caption-3"><title hwp:id="title-8"><italic toggle="yes">EFL1</italic> variants display somatic mosaicism.</title><p hwp:id="p-17"><bold>a</bold> All three patients demonstrate a partial LOH in chromosome 15, as indicated by the deviation from VAF 0.5. The variant origin is indicated by the red or blue dots, whereas parental samples were not available for II-1. The location of <italic toggle="yes">EFL1</italic> is indicated by a red dotted line. <bold>b</bold> Schematic diagram of the single cell LOH experiment shown in c-d, where a red cell symbolizes an LOH-carrying cell. <bold>c-d</bold> Single cell LOH profiles from I-1 bone marrow (<bold>c</bold>) and III-1 buccal swab samples (<bold>d</bold>), the upper plots denote cells without LOH, and the lower plots represent cells with a complete LOH in chr15. The plots on the right show chr15 with the variant origin shown in red or blue dots. <bold>e</bold> VAF of the <italic toggle="yes">EFL1</italic> variant in multiple tissue samples from I-1. VAF, variant allele frequency. <bold>f</bold> Genetic process underlying selection of <italic toggle="yes">EFL1</italic><sup>p.Thr1069Ala</sup> cells in the patients.</p></caption><graphic xlink:href="483362v3_fig2" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-18">Conversely, AFs of p.Gly827TrpfsTer13 in the peripheral blood and bone marrow were ∼0.15 and displayed complementary frequencies to those of p.Thr1069Ala (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Fig. 2e</xref>). This observation suggested that the mosaic UPD was restricted at least to the bone marrow. These results were concordant with the Sanger sequencing results (Figs. S9-10). The degree of mosaicism in the bone marrow tissue changed dynamically over the time course of I-1, but did not strongly correlate with the clinical status of the patient (Fig. S11). These results suggest that compound heterozygous variants that may disable <italic toggle="yes">EFL1</italic> function and impair cell survival formed a cellular environment such that cells with (less damaging) recombinant alleles gained survival advantages over the parental ones (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-6" hwp:rel-id="F2">Fig. 2f</xref>).</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-9">EFL1 deficiency impairs 80S ribosome assembly</title><p hwp:id="p-19">Our interpretation of the genetic analysis assumes that the <italic toggle="yes">EFL1</italic> variants are pathogenic, and harbor a gradient of severity (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-7" hwp:rel-id="F2">Fig. 2f</xref>). More specifically, p.His30Arg possesses a comparable severity with the frameshift variant (p.Gly827TrpfsTer13), and these two are more severe than p.Thr1069Ala. To test this, we measured ribosome assembly function in the presence of the <italic toggle="yes">EFL1</italic> variants, as EFL1 is known to mediate GTP hydrolysis-coupled release of eukaryotic translation initiation factor 6 (eIF6) together with SBDS during the maturation of the 60S ribosome subunit<sup><xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-3" hwp:rel-id="ref-7">7</xref>,<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-4" hwp:rel-id="ref-15">15</xref>,<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-2" hwp:rel-id="ref-16">16</xref></sup>. Thus, we monitored the ribosomal assembly status of the wild type, siRNA-, or CRISPR/Cas9-mediated ablation of <italic toggle="yes">EFL1</italic> (<italic toggle="yes">EFL1</italic><sup><italic toggle="yes">KD</italic></sup> or <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">-/-</italic></sup>) in HeLa and K562 cell lines to further elucidate the molecular function of the mutant protein (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Fig. 3a</xref>; Fig. S12). Polysome profiling of the <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">KD</italic></sup> and <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">-/-</italic></sup> cells showed a significantly reduced 80S peak (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Fig. 3b-c</xref>; Fig. S12). This abnormal polysome profile was completely rescued after the introduction of FLAG-tagged wild type <italic toggle="yes">EFL1</italic> but not by the clones that harbored the mutations (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Fig. 3b-c</xref>; Fig. S13). Interestingly, <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">His30Arg</italic></sup> failed to rescue the mutant phenotype, whereas <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> displayed a moderate effect on ribosome assembly. These results indicated that EFL1 plays a crucial role in ribosome assembly, and <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">His30Arg</italic></sup> possesses a null function, while <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> is hypomorphic.</p><fig id="fig3" position="float" fig-type="figure" orientation="portrait" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4 xref-fig-3-5 xref-fig-3-6 xref-fig-3-7"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;483362v3/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Fig. 3.</label><caption hwp:id="caption-4"><title hwp:id="title-10">Nonsynonymous variants in <italic toggle="yes">EFL1</italic> disrupt 80S assembly with varying severities.</title><p hwp:id="p-20"><bold>a</bold> Immunoblot showing the CRISPR-knockout of <italic toggle="yes">EFL1</italic> in HeLa cells. <bold>b</bold> Polysome profiling results of <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">+/+</italic></sup> and <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">-/-</italic></sup> cells followed by transfection of vectors containing <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">WT</italic></sup>, <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> or <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">His30Arg</italic></sup> (as indicated in the top right corner of each plot). Note the different heights of 60S and 80S peaks in each experiment (dotted lines). <bold>c</bold> Quantification of the polysome profiling results, displaying the relative occupancy of different ribosome statuses. Each bar corresponds to each experiment in (<bold>b</bold>). <bold>d</bold> Immunoblots of EFL1 and eIF6 in wild type or <italic toggle="yes">EFL1</italic><sup>-/-</sup> HeLa cells with or without transfection of vectors containing <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">WT</italic></sup>, <italic toggle="yes">EFL1</italic><sup>p.Thr1069Ala</sup> or <italic toggle="yes">EFL1</italic><sup>p.His30Arg</sup>. <bold>e</bold> Immunoblots of eIF6 from ribosomal fractions that best represent 60S and 80S of HeLa cells, and each corresponds to the polysome profiles shown above.</p></caption><graphic xlink:href="483362v3_fig3" position="float" orientation="portrait" hwp:id="graphic-4"/></fig></sec><sec id="s2d" hwp:id="sec-6"><title hwp:id="title-11">Molecular mechanism of EFL1-mediated SDS pathogenesis</title><p hwp:id="p-21">Next, we explored the molecular function of the variants in ribosome assembly. Variant function was not mediated via phosphorylation of Thr1069, aberrant subcellular localization of EFL1, or changes in binding affinity to SBDS (Fig. S14). Next, since the release of eIF6 from 60S is a crucial step for 80S assembly and is mediated by SBDS-EFL1, we investigated eIF6 level changes by altering <italic toggle="yes">EFL1</italic>. The assessment of eIF6 in wild type and <italic toggle="yes">EFL1</italic><sup>-/-</sup> cells revealed that the absence of <italic toggle="yes">EFL1</italic> induced eIF6 levels, which was partially rescued by the introduction of <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> or <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">His30Arg</italic></sup> (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-4" hwp:rel-id="F3">Fig. 3d</xref>). Immunoblot analysis of each ribosomal subunit-bound fraction revealed that eIF6 was more highly enriched in 60S ribosome fraction of the <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">-/-</italic></sup> cells as compared to the wild type or <italic toggle="yes">EFL1</italic>-overexpressed cells (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-5" hwp:rel-id="F3">Fig. 3e</xref>). Remarkably, introduction of <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> rescued the increased eIF6 in the 60S fraction, whereas <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">His30Arg</italic></sup> failed to do so (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-6" hwp:rel-id="F3">Fig. 3e</xref>; Fig. S15). Also, absence of <italic toggle="yes">EFL1</italic> caused an impaired shuttling of cytoplasmic eIF6 back to the nucleus, consistent with the previous observation (Fig. S16)<sup><xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-5" hwp:rel-id="ref-15">15</xref></sup>. This result, along with the observation that changes in eIF6 and SBDS were not due to transcription levels (Fig. S17), implies that the blocked exclusion of eIF6 and SBDS from the 60S ribosomal subunit is one of the mechanisms by which our mutant protein functions, which results in impaired 80S ribosome assembly. This result also supports our hypothesis that the severity of p.His30Arg is higher than that of p.Thr1069Ala.</p></sec><sec id="s2e" hwp:id="sec-7"><title hwp:id="title-12">Deficiency of <italic toggle="yes">EFL1</italic> orthologs reproduces SDS phenotypes in zebrafish and mouse models</title><p hwp:id="p-22">To determine whether the milder allele (<italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup>) was still pathogenic enough to cause SDS, a morpholino-targeting zebrafish model of <italic toggle="yes">efl1</italic> was subjected to rescue experiments (Fig. S18). The <italic toggle="yes">efl1</italic> morphants had smaller heads and eyes as wells as slightly bent tails and displayed an increased number of apoptotic cells during development (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Fig. 4a</xref>). Also, primitive erythrocytes and granulocytes were significantly reduced in the <italic toggle="yes">efl1</italic> morphants, indicating impaired primitive hematopoiesis in these embryos (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Fig. 4a-b</xref>). All phenotypes were rescued by the introduction of the wild type human <italic toggle="yes">EFL1</italic> mRNA, but less so by the <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> mRNA (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Fig. 4c-e</xref>), confirming that the milder <italic toggle="yes">efl1</italic> allele caused SDS-like features in zebrafish.</p><fig id="fig4" position="float" fig-type="figure" orientation="portrait" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3 xref-fig-4-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;483362v3/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Fig. 4.</label><caption hwp:id="caption-5"><title hwp:id="title-13">Zebrafish <italic toggle="yes">efl1</italic> mutants model human SDS features.</title><p hwp:id="p-23"><bold>a-b</bold> Cell death (<bold>a</bold>) and neutrophil production (<bold>b</bold>) of 48 hpf zebrafish embryos by the knockdown of <italic toggle="yes">efl1</italic> and <italic toggle="yes">sbds</italic>. (<bold>c-e</bold>) Rescue of <italic toggle="yes">efl1</italic> MO animals using human <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">WT</italic></sup> or <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> RNA, documenting morphology (<bold>c</bold>), hemoglobin production (<bold>d</bold>) and neutrophil production (<bold>e</bold>). **, <italic toggle="yes">P</italic> &lt; 0.01; ***, <italic toggle="yes">P</italic> &lt; 0.0005; ****, <italic toggle="yes">P</italic> &lt; 0.0001. hpf, hours post fertilization.</p></caption><graphic xlink:href="483362v3_fig4" position="float" orientation="portrait" hwp:id="graphic-5"/></fig><p hwp:id="p-24">In addition, mouse models were created to further investigate the impact of <italic toggle="yes">Efl1</italic> dysfunction. <italic toggle="yes">Efl1</italic> knock-out and p.Thr1076Ala knock-in mice (mouse Thr1076 is orthologous to human Thr1069; herein designated as <italic toggle="yes">Efl1</italic><sup><italic toggle="yes">m</italic></sup>) were generated and subjected to phenotypic analyses (Fig. S19). Embryos that were homozygous for the null allele (<italic toggle="yes">Efl1</italic><sup><italic toggle="yes">-/-</italic></sup>) were not retrieved on embryonic day (E) 8.5, implying the essential requirement of the gene in early embryogenesis (Fig. S19). On the other hand, mice homozygous for the knock-in allele (<italic toggle="yes">Efl1</italic><sup><italic toggle="yes">m/m</italic></sup>) were viable and healthy (Fig. S19), indicating a differential phenotypic tolerance between mice and humans. To model an accurate <italic toggle="yes">Efl1</italic> dose that may induce an SDS-like phenotypic expression, we inter-crossed the two strains and compared phenotypes of the compound heterozygous (CH) animals (<italic toggle="yes">Efl1</italic><sup><italic toggle="yes">m/-</italic></sup>) to the littermates (<italic toggle="yes">Efl1</italic><sup><italic toggle="yes">+/+</italic></sup>, <italic toggle="yes">Efl1</italic><sup><italic toggle="yes">+/-</italic></sup> and <italic toggle="yes">Efl1</italic><sup><italic toggle="yes">+/m</italic></sup>), with an emphasis on the major SDS symptoms. The CH mice were smaller (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Fig. 5a-b</xref>) and died earlier (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-2" hwp:rel-id="F5">Fig. 5c</xref>). The blood counts revealed reduced hemoglobin, white blood cells and platelets (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-3" hwp:rel-id="F5">Fig. 5d</xref>), and the bone marrow images displayed a consistent deficiency (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-4" hwp:rel-id="F5">Fig. 5e</xref>). These results validated our observation that the reduced function of the <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> variant caused SDS in human patients. To determine whether Efl1 expression was affected by the <italic toggle="yes">Efl1</italic><sup><italic toggle="yes">m</italic></sup> variant, we measured the protein expression from E17.5 livers (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-5" hwp:rel-id="F5">Fig. 5f</xref>). The liver heterozygous for <italic toggle="yes">Efl1</italic><sup><italic toggle="yes">m</italic></sup> (<italic toggle="yes">Efl1</italic><sup><italic toggle="yes">+/m</italic></sup>) showed reduced Efl1 expression, suggesting that the variant not only reduced Efl1 activity, but also destabilized the protein. The expression of eIF6 was also detected in the CH livers and was increased compared to the wild type livers, which was consistent with our previous observation in the HeLa cells (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-6" hwp:rel-id="F5">Fig. 5g</xref>). Ribosome profiling of the wild type and CH livers revealed that the CH livers showed a lower 80S peak compared to the wild type livers (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-7" hwp:rel-id="F5">Fig. 5h-i</xref>).</p><fig id="fig5" position="float" fig-type="figure" orientation="portrait" hwp:id="F5" hwp:rev-id="xref-fig-5-1 xref-fig-5-2 xref-fig-5-3 xref-fig-5-4 xref-fig-5-5 xref-fig-5-6 xref-fig-5-7 xref-fig-5-8"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;483362v3/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Fig. 5.</label><caption hwp:id="caption-6"><title hwp:id="title-14">Mouse <italic toggle="yes">Efl1</italic> mutants model human SDS features.</title><p hwp:id="p-25"><bold>a</bold> Body sizes of the CH mice (<italic toggle="yes">Efl1</italic><sup><italic toggle="yes">m/-</italic></sup>) at three weeks compared to the wild type littermates. <bold>b</bold> Body weight curves of the CH animals compared to the wild types. Males (left) and females (right) are plotted separately. <bold>c</bold> Survival plot. <bold>d</bold> Hematopoietic features of the CH animals, measured at postnatal days 35-42. <bold>e</bold> H&amp;E staining of the bone marrows from 69- and 85-day-old femurs. <bold>f</bold> Level of Efl1 protein in the wild type or CH livers. <bold>g</bold> Immunoblots of eIF6 from wild type or CH livers. <bold>h</bold> Polysome profiling results of the wild type or CH mouse livers. <bold>i</bold> Quantification of the polysome profiling results. Scale bars in (<bold>a</bold>) and (<bold>e</bold>) = 1 cm and 0.5 mm.</p></caption><graphic xlink:href="483362v3_fig5" position="float" orientation="portrait" hwp:id="graphic-6"/></fig></sec><sec id="s2f" hwp:id="sec-8"><title hwp:id="title-15">Screening downstream factors of EFL1 dysfunction</title><p hwp:id="p-26">To further investigate the features of downstream genes that are strongly affected by the reduced EFL1 function, we performed RNA-seq on the total RNA, 40S-, 80S- and polysome-bound RNAs from wild type and <italic toggle="yes">EFL1</italic><sup>-/-</sup> K562 cells (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-1" hwp:rel-id="F6">Fig. 6a</xref>; Fig. S20). The 60S-bound RNAs were not analyzed as it is unlikely that the large subunit will bind with RNA by itself. The 248 genes that were decreased in the 80S-bound fraction compared to the 40S-bound fraction in the mutant cells were extracted. A gene ontology analysis suggests that RP genes (GO:0003735) were the major constituents of the genes that were reduced by the absence of <italic toggle="yes">EFL1</italic> (<italic toggle="yes">P</italic><sub><italic toggle="yes">adj</italic></sub> = 5.2 × 10<sup>−77</sup>, adjusted by the Benjamini-Hochberg method; <xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-2" hwp:rel-id="F6">Fig. 6b-c</xref>). There was no significantly enriched gene group in the increased gene set. The fractions of the transcripts bound by 40S-, 80S-, or polysome differed substantially for the RP genes in the absence of <italic toggle="yes">EFL1</italic> (<italic toggle="yes">P</italic> &lt; 1.0 × 10<sup>−13</sup> for differences in both 40S-and 80S-bound transcripts, Wilcoxon signed-rank test), whereas the <italic toggle="yes">TP53</italic> target genes and all other genes did not show such a change (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-3" hwp:rel-id="F6">Fig. 6d</xref>, <italic toggle="yes">P</italic> &gt; 0.05, Wilcoxon signed-rank test). Next, we compared whether transcript sizes (Fig. S21), expression levels, or consensus sequence elements in the 5’ UTRs may serve as a factor that enabled RP-specific regulation. Notably, highly-expressed RP transcripts with a terminal oligo-pyrimidine (TOP) element (5’-CUUYCUUUUNS-3’) were specifically altered (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-4" hwp:rel-id="F6">Fig. 6e</xref>; Fig. S22; <italic toggle="yes">P</italic> = 6.9 × 10<sup>−7</sup>). This result revealed that, among all the genes in the genome, 80S ribosome assembly of RP transcripts containing a TOP element were heavily dependent on the normal EFL1 function.</p><fig id="fig6" position="float" fig-type="figure" orientation="portrait" hwp:id="F6" hwp:rev-id="xref-fig-6-1 xref-fig-6-2 xref-fig-6-3 xref-fig-6-4 xref-fig-6-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;483362v3/FIG6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F6</object-id><object-id pub-id-type="publisher-id">fig6</object-id><label>Fig. 6.</label><caption hwp:id="caption-7"><title hwp:id="title-16">EFL1 is required for RP synthesis.</title><p hwp:id="p-27"><bold>a</bold> Schematic diagram of the RNA expression analysis from K562 ribosomal fractions. <bold>b</bold> Volcano plot of the genes that were differentially enriched in the 80S fraction compared to the 40S fraction (left). GO analysis of the 248 downregulated genes (right). Red dots depict RP genes (GO:0022625 and GO:0022627, <italic toggle="yes">n</italic> = 118). <bold>c</bold> Fold change of 80S enriched genes normalized by 40S, depicted against transcriptome. Red; significantly downregulated RP genes in (<bold>b</bold>). Blue; other RP genes. <bold>d</bold> Fractions of 40S-, 80S- or polysome-bound RNAs for RP genes (<italic toggle="yes">n</italic> = 108, left), <italic toggle="yes">TP53</italic> target genes (<italic toggle="yes">n</italic> = 51, middle) and all other genes (<italic toggle="yes">n</italic> = 11,812, right) are displayed. Wilcoxon signed-rank test, *. <italic toggle="yes">P</italic> = 4.7 × 10<sup>−14</sup>, **. <italic toggle="yes">P</italic> = 1.5 × 10<sup>−26</sup>. All other test <italic toggle="yes">P-</italic>values &gt; 0.05. <bold>e</bold> Consensus sequence profile of downregulated RP gene 5’ UTRs, deducing a TOP sequence. Rel. seq. cons. denotes relative sequence conservation from the MEME run.</p></caption><graphic xlink:href="483362v3_fig6" position="float" orientation="portrait" hwp:id="graphic-7"/></fig></sec></sec><sec id="s3" hwp:id="sec-9"><title hwp:id="title-17">Discussion</title><p hwp:id="p-28">We identified and described a unique bone marrow-specific somatic UPD event that preferentially selects cells with <italic toggle="yes">EFL1</italic> alleles of a weaker severity. Although other parts of the body may suffer from biallelic variants in <italic toggle="yes">EFL1</italic>, composed of more damaging one and the milder one, the hematological system was partially rescued by a somatic UPD resulting in a homozygous <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> with a weaker severity. We provided evidence suggesting that the majority of the cells that carry <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> in a homozygous manner is still pathogenic. We hypothesize that a somatic UPD in the patients could occur and be detected because of the dynamic nature of bone marrow, where the whole stem cell can be potentially replaced by a few clones. Indeed, the somatic UPD was not detected in other solid organs or tissues that were available for investigation. Two lines of evidence suggest infrequent LOH events in the <italic toggle="yes">EFL1</italic> locus in normal populations (2.7-7.7 × 10<sup>−4</sup>; see Results). The odds of having all the p.Thr1069Ala and p.His30Arg variants and the LOH by UPD in the <italic toggle="yes">EFL1</italic> locus for one person by chance is roughly estimated as 1 in 3 trillion, indicating that detectable UPD is not an independent event but is associated with the biallelic <italic toggle="yes">EFL1</italic> variants. It is still not clear if the EFL1 dysfunction somehow contributed to the occurrence of UPD, causing the resulting clone to be expanded by positive selection. Nevertheless, the degree of mosaicism did not seem to directly determine clinical severity (Fig. S11). One could further delineate a more accurate temporal and spatial occurrence of the event if additional clinical samples become available.</p><p hwp:id="p-29">Several lines of evidence from our experiments suggest that although p.Thr1069Ala is the mildest among the variants that we found, it is still functional and hypomorphic: (1) the parents of patients that were heterozygous for <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> were asymptomatic, whereas the patients carried the variant in a homozygous status in their bone marrow and showed the pathology; (2) a ribosome profiling assay using a variant allele partially rescued the 80S assembly problem, whereas the wild type allele completely rescued it (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-7" hwp:rel-id="F3">Fig. 3</xref>); (3) <italic toggle="yes">efl1</italic> MO-treated zebrafish were partially rescued by the variant-containing RNA (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-4" hwp:rel-id="F4">Fig. 4</xref>); and (4) <italic toggle="yes">Efl1</italic><sup><italic toggle="yes">m/-</italic></sup> mice displayed an SDS-like phenotype, which was of an intermediate severity relative to the <italic toggle="yes">Efl1</italic><sup><italic toggle="yes">-/-</italic></sup> and <italic toggle="yes">Efl1</italic><sup><italic toggle="yes">+/-</italic></sup> mice (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-8" hwp:rel-id="F5">Fig. 5</xref>). It is notable that although our mouse model successfully phenocopied most of the SDS features, the genotype was not in complete concordance with that of human patients. Our mouse model with <italic toggle="yes">Efl1</italic><sup><italic toggle="yes">m/m</italic></sup> did not show significant phenotypes, whereas human patients with bone marrow specific homozygous <italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup> by somatic UPD still had hematological abnormalities such as anemia and neutropenia. This discrepancy between the two species is not rare<sup><xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref>,<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref></sup>, and it again underscores differences in tolerance to a given variant, perhaps due to different physiological and genetic systems, which is critical in modeling human clinical features in mice.</p><p hwp:id="p-30">Nonetheless, we demonstrated that the altered function of EFL1 specifically influenced the translation of RP genes containing a TOP element in the 5’ UTR, which led to a mechanistic mimicry of Diamond-Blackfan anemia, which is another ribosomopathy caused by insufficient RP doses<sup><xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>,<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref></sup>. The activation of TP53 is considered as a targetable downstream pathway that leads to SDS or a DBA phenotype<sup><xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref>-<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref></sup>. However, our data suggest that the loss of <italic toggle="yes">EFL1</italic> does not induce TP53 activation, which is consistent with previous studies of the zebrafish <italic toggle="yes">sbds</italic> model and DBA (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-5" hwp:rel-id="F6">Fig. 6d</xref>)<sup><xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref>,<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref></sup>.</p><p hwp:id="p-31">It is known that LARP1 directly binds to the TOP element of RP genes to repress translation in a phosphorylation-dependent manner and that mTOR partially regulates LARP1 phosphorylation<sup><xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref>,<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref></sup>. To determine if we could utilize this pathway to de-repress RP translation and rescue the SDS phenotype in the animal models, we considered a molecular signaling pathway that may regulate RP gene translation through the TOP element. However, both LARP1 binding to RP TOP elements and mTOR signaling were unchanged in the mutant cells, suggesting an alternative mechanism that may regulate RP translation (data not shown).</p><p hwp:id="p-32">Here, we demonstrated a mechanism by which biallelic variants of <italic toggle="yes">EFL1</italic> phenocopied classical SDS in three unrelated patients. The bone marrow-specific somatic UPD in these patients mitigated the potentially catastrophic hematological phenotype by homozygosing the less damaging variant (<italic toggle="yes">EFL1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1069Ala</italic></sup>). We demonstrated that defective EFL1 caused impaired 80S ribosomal assembly and that the zebrafish and mouse models displayed similar features to humans through the alteration of 80S ribosome assembly of RP transcripts. An extensive search of such SDS patients may provide more insight into the development of somatic mosaicism and subsequent molecular cascades that may lead to new avenues of treatment for ribosomopathy.</p></sec><sec id="s4" hwp:id="sec-10"><title hwp:id="title-18">Materials and methods</title><sec id="s4a" hwp:id="sec-11"><title hwp:id="title-19">Patient recruitment and sampling</title><p hwp:id="p-33">Patient enrollment and sampling were conducted under the approval of the Institutional Review Board of Seoul National University Hospital (IRB number: H-1408-014-599). Patients or their parents were provided an informed consent for genetic testing and collecting blood, buccal swab, scalp hair, urine and clipped nails. Biopsy samples of I-1 (esophagus, stomach, duodenum, colon and liver) were retrieved from the Department of Pathology of Seoul National University for a research purpose.</p></sec><sec id="s4b" hwp:id="sec-12"><title hwp:id="title-20">Whole exome sequencing and variant calling</title><p hwp:id="p-34">Trio whole exome sequencing (WES) was performed on one family (I-1, I-2, and I-3) and singleton WES for two families (II-1 and III-1) at Theragen Etex (Suwon, Korea) using genomic DNA extracted from whole blood. Exome was captured using SeqCap EZ Exome v2 Kit (Roche Sequencing, Madison, WI) or SureSelect Human All Exon V5 (Agilent Technologies, Santa Clara, CA) and sequenced by HiSeq 2500 or HiSeq 4000 (Illumina, Inc., San Diego, CA). Paired-end sequencing was performed with read lengths of 75 or 100 base pairs. The raw reads were aligned by BWA MEM software <sup><xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref></sup>. Variants were called by Samtools and annotated by in-house pipeline and SnpEff <sup><xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-2" hwp:rel-id="ref-34">34</xref>-<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref></sup>.</p></sec><sec id="s4c" hwp:id="sec-13"><title hwp:id="title-21">Single nucleus SNP microarray</title><p hwp:id="p-35">Nuclei of frozen bone marrow cells from I-1, where a majority of the cells were disrupted during freezing, were prepared and collected manually with a pipette under a phase-contrast microscope. Buccal swab of III-1 was resuspended in 1 ml of PBS and centrifuged at 300 <italic toggle="yes">g</italic> for 3 min. Supernatant was discarded and pellet was resuspended in PBS. This suspension was moved to a 100 ml cell culture dish. Single cells were manually picked up with a pipette under a phase-contrast microscope. These single cells or nuclei were whole-genome amplified by a REPLI-g Single Cell Kit (Qiagen, Venlo, the Netherlands) for 3 hours. Amplified genomes were genotyped by Infinium<sup>®</sup> OmniExpress-24 v1.2 (Illumina, Inc.).</p></sec><sec id="s4d" hwp:id="sec-14"><title hwp:id="title-22">Sample-barcoded amplicon sequencing</title><p hwp:id="p-36">Genomic DNAs extracted from multiple individuals and tissues were PCR amplified with primers shown in Table S6, with following condition: 3 min at 95°C, followed by 20 cycles (30 sec at 95°C, 30 sec at 57°C, and 20 sec at 72°C), and a final extension at 5 min at 72°C. Barcoded PCRs were performed with 1 µl of first PCR product as templates using tissue-specific barcoded primers (Table S7). Same reverse, forward and reverse primers of <italic toggle="yes">EFL1, WDR76</italic> and rs1044032 with Sanger sequencing were used for barcoded PCR products, respectively. The second PCR condition was: 3 min at 95°C, followed by 20 cycles (30 sec at 95°C, 30 sec at 57°C, and 20 sec at 72°C), and a final extension at 5 min at 72°C.</p></sec><sec id="s4e" hwp:id="sec-15"><title hwp:id="title-23">Molecular dynamics (MD) simulation of EFL1</title><p hwp:id="p-37">The initial atom coordinates for MD simulations were from the Protein Data Bank accession number 5ANC <sup><xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-4" hwp:rel-id="ref-7">7</xref></sup>. Input files were prepared with PSFGEN, SOLVATE, and IONIZE plug-ins of VMD <sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref></sup>. Each simulation used explicit TIP3 solvent and periodic boundaries. Each unit cell contained one molecule of the entire preinitiation complex. The unit cells were ∼210 Å x 180 Å x 190 Å in size and contained ∼700,000 atoms. Sodium and chloride were added to make the total ionic strength 100 mM. MD simulations were performed in triplicate (each 50 ns in length) with a CHARMM36 force field <sup><xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref></sup> using NAMD2 <sup><xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref></sup> on the Bebop cluster of the Laboratory Computing Resource Center at Argonne National Laboratory. MD simulations were run at P = 1 atm, T = 310 K, with a 1 fs integration time and a 12 Å cutoff distance. Nonbonded forces were calculated every two steps and electrostatic forces were calculated every four. Pressure and temperature were maintained using a Langevin piston and bath. Atom coordinates were recorded every 10 ps. MD trajectories were visualized and analyzed with VMD and PyMol.</p></sec><sec id="s4f" hwp:id="sec-16"><title hwp:id="title-24">Polysome profiling</title><p hwp:id="p-38">To maintain the binding of mRNA to ribosome subunits, cycloheximide (Sigma-Aldrich, St. Louis, MO) (100 ug/ml) was added to cell culture media and incubated for 10 min at 37°C. After incubation, cells were washed with cold PBS including cycloheximide (10 ug/ml) twice, then lysed with 1 ml of polysome lysis buffer (20 mM HEPES pH 7.6, 5 mM MgCl<sub>2</sub>, 125 mM KCl, 1% NP-40, 2 mM DTT) supplemented with cycloheximide (100 ug/ml), protease inhibitor cocktail (EDTA-free; Roche) and RNase inhibitor (Invitrogen, Carlsbad, CA) on ice. Cell lysates were tumbled for 20 min at 4°C and centrifuged at 13,200 rpm for 20 min. The supernatants were fractionated in 17.5-50% linear sucrose gradients by ultracentrifugation (35,000 rpm for 160 min) in a Beckman ultracentrifuge using SW41-Ti rotor. Gradients were eluted with a gradient fractionator (Brandel, Gaithersburg, MD) and monitored with a UA-5 detector (ISCO). Equal volume of each polysome fraction was used for determining the level of eIF6 by Western blot analysis.</p></sec><sec id="s4g" hwp:id="sec-17"><title hwp:id="title-25">RNA sequencing from polysome fractions</title><p hwp:id="p-39">RNA was extracted from polysome fractionation. RNA sequencing library was constructed using a TruSeq stranded total RNA kit (Illumina Inc.) with rRNA depletion. 100 bp paired-end sequencing was performed using HiSeq 2500, producing &gt;5 Gb for each sample. Transcripts with polysome-bound RNA count &gt;10 were selected and subjected to calculation of fractions of 40S-, 80S- or polysome-bound RNA molecules for a given gene.</p></sec><sec id="s4h" hwp:id="sec-18"><title hwp:id="title-26">Zebrafish experiments</title><p hwp:id="p-40">Zebrafish embryos were co-injected with <italic toggle="yes">efl1</italic> morpholino (MO) and normal or mutated human <italic toggle="yes">EFL1</italic> mRNA at 1-2 cell stage. To evaluate the rescue efficacy of each co-injected <italic toggle="yes">EFL1</italic> mRNA, the number of neutrophils and primary erythrocytes were assessed. For neutrophils, individual Sudan Black stained cells in the caudal region of the embryo, posterior to the anal opening, were counted and the absolute number of positive cells were used for phenotypic comparison. For primary erythrocytes, the degree of o-dianisidine staining was qualitatively compared using the percentage of o-dianisidine stained embryos within the population, since it is not technically possible to count individual erythrocytes.</p></sec><sec id="s4i" hwp:id="sec-19"><title hwp:id="title-27">Efl1 mutant mouse strain construction, maintenance and experiments</title><p hwp:id="p-41">All the mouse experiments were performed under the standard protocols approved by IACUC (#17-0148-S1A0). <italic toggle="yes">Efl1</italic> knock-out (<italic toggle="yes">Efl1</italic><sup><italic toggle="yes">-</italic></sup>) strain was constructed by introducing a 10-base deletion in the 10<sup>th</sup> exon of the gene in C57BL6/J strain using CRISPR/Cas9 system in Macrogen (Seoul, Korea). One cell embryos were microinjected with two sgRNAs (5’-ACTTCTTTAGGATTAAAAATTGG-3’ and 5’-CCGAGGACAGCGTGGGATATGGG-3’) and Cas9 protein mixture, incubated and transplanted into pseudopregnant recipient ICR mice. <italic toggle="yes">Efl1</italic> knock-in (<italic toggle="yes">Efl1</italic><sup><italic toggle="yes">p</italic>.<italic toggle="yes">Thr1076Ala</italic></sup>) variant was generated in C57BL6/J in University of Utah Mutation Generation and Analysis Core using two sgRNAs (5’-GTTCTGGGTGCCGACCACGG-3’ and 5’-GTGCAGGTACTCCTCCTCCG-3’) and in the presence of oligodeoxynucleotides which includes the ACC&gt;GCC change mimicking the p.Thr1069Ala and an <italic toggle="yes">Mbo</italic>I site for genotyping. Genotyping strategies of the wild type and mutant alleles are described in supplemental Methods. For phenotypic evaluations, wild type and mutant mice from the same litter were sacrificed and dissected for peripheral blood extraction, pancreas pathology and skeletal structure analysis. 300 ul of peripheral blood was extracted from 35-42-day animals and subjected to a complete blood count and differential tests.</p></sec></sec><sec sec-type="supplementary-material" hwp:id="sec-20"><title hwp:id="title-28">Supporting information</title><supplementary-material position="float" orientation="portrait" hwp:id="DC1"><object-id pub-id-type="other" hwp:sub-type="slug">DC1</object-id><label>Supplementary materials</label><media xlink:href="supplements/483362_file02.docx" position="float" orientation="portrait" hwp:id="media-1"/></supplementary-material></sec></body><back><sec id="s5" hwp:id="sec-21"><title hwp:id="title-29">Author contributions</title><p hwp:id="p-42">M. Choi, H.J. Kang, and H.H. Kim conceived the study. S. Lee and M. Choi performed genetic analysis and statistical evaluations. C.H. Shin, S. Lee, S.D. Jeong, H.H. Kim, J. Lee, and M. Choi performed molecular biology and biochemistry experiments and assessed the results. J. Lee, S. Lee, S.J. Son, M. Choi, and J.K. Seong performed mouse experiments. J.-D. Kim, A.-R. Kim, and S.-W. Jin performed zebrafish experiments. C.R. Hong, J.S. Ko, Y.B. Sohn, O.-H. Kim, J.M. Ko, T.-J. Cho, and H.J. Kang provided patient care and generated clinical data. N.T. Wright, O. Kokhan, and T. Yoo analyzed protein structure. M. Choi, S. Lee, C.H. Shin, C.R. Hong, J. Lee, H.J. Kang, and H.H. Kim wrote the manuscript. All authors approved the final version of the manuscript.</p></sec><ack hwp:id="ack-1"><title hwp:id="title-30">Acknowledgements</title><p hwp:id="p-43">We appreciate the patients and families that participated in this study. We thank Jung-Ah Kim and Hyoung-Jin Kim at Seoul National University Hospital for collecting and interpreting hematological data and for interpreting images. We thank the University of Utah Mutation Generation and Detection Core for construction of the <italic toggle="yes">Efl1</italic> knock-in mice. This study was partly supported by grants from the National Research Foundation of Korea (2014M3C9A2064686, 2019R1A2C2010789 to M.C. and 2017R1A2A2A05069691 to H.H.K.) and National Science Foundation (REU CHE-1062629 and RUI MCB-1607024) awards to N.T.W.. This research was partly supported by Korea Mouse Phenotyping Project (2013M3A9D5072550) of the Ministry of Science, ICT and Future Planning through the National Research Foundation. OK gratefully acknowledges the computing resources provided by Bebop, a high-performance computing cluster operated by the Laboratory Computing Resource Center at Argonne National Laboratory. The authors declare no competing financial interests.</p></ack><glossary hwp:id="glossary-1"><title hwp:id="title-31">Abbreviations used</title><def-list hwp:id="def-list-1"><def-item hwp:id="def-item-1"><term hwp:id="term-1">CH</term><def hwp:id="def-1"><p hwp:id="p-44">compound heterozygous</p></def></def-item><def-item hwp:id="def-item-2"><term hwp:id="term-2">DBA</term><def hwp:id="def-2"><p hwp:id="p-45">Diamond-Blackfan anemia</p></def></def-item><def-item hwp:id="def-item-3"><term hwp:id="term-3">LOH</term><def hwp:id="def-3"><p hwp:id="p-46">loss of heterozygosity</p></def></def-item><def-item hwp:id="def-item-4"><term hwp:id="term-4">RP</term><def hwp:id="def-4"><p hwp:id="p-47">ribosomal protein</p></def></def-item><def-item hwp:id="def-item-5"><term hwp:id="term-5">SDS</term><def hwp:id="def-5"><p hwp:id="p-48">Schwachman-Diamond syndrome</p></def></def-item><def-item hwp:id="def-item-6"><term hwp:id="term-6">TOP</term><def hwp:id="def-6"><p hwp:id="p-49">terminal oligo-pyrimidine</p></def></def-item><def-item hwp:id="def-item-7"><term hwp:id="term-7">UPD</term><def hwp:id="def-7"><p hwp:id="p-50">uniparental disomy</p></def></def-item><def-item hwp:id="def-item-8"><term hwp:id="term-8">VUS</term><def hwp:id="def-8"><p hwp:id="p-51">variants of unknown significances</p></def></def-item></def-list></glossary><ref-list hwp:id="ref-list-1"><title hwp:id="title-32">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1 xref-ref-1-2 xref-ref-1-3"><label>1</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Boocock G. R."><surname>Boocock</surname>, <given-names>G. R.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-2">Mutations in SBDS are associated with Shwachman-Diamond syndrome</article-title>. <source hwp:id="source-1">Nat Genet</source> <volume>33</volume>, <fpage>97</fpage>-<lpage>101</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ng1062</pub-id> (<year>2003</year>).</citation></ref><ref id="c2" hwp:id="ref-2"><label>2</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Shimamura A."><surname>Shimamura</surname>, <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-3">Shwachman-Diamond syndrome</article-title>. <source hwp:id="source-2">Semin Hematol</source> <volume>43</volume>, <fpage>178</fpage>-<lpage>188</lpage>, doi:<pub-id pub-id-type="doi">10.1053/j.seminhematol.2006.04.006</pub-id> (<year>2006</year>).</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><label>3</label><citation publication-type="other" citation-type="journal" ref:id="483362v3.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Dror Y."><surname>Dror</surname>, <given-names>Y.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-4">Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome</article-title>. <source hwp:id="source-3">Ann N Y Acad Sci 1242</source>, <fpage>40</fpage>-<lpage>55</lpage>, doi:<pub-id pub-id-type="doi">10.1111/j.1749-6632.2011.06349.x</pub-id> (<year>2011</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Kuijpers T. W."><surname>Kuijpers</surname>, <given-names>T. W.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-5">Hematologic abnormalities in Shwachman Diamond syndrome: lack of genotype-phenotype relationship</article-title>. <source hwp:id="source-4">Blood</source> <volume>106</volume>, <fpage>356</fpage>-<lpage>361</lpage>, doi:<pub-id pub-id-type="doi">10.1182/blood-2004-11-4371</pub-id> (<year>2005</year>).</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>5</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Dror Y."><surname>Dror</surname>, <given-names>Y.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Freedman M. H."><surname>Freedman</surname>, <given-names>M. H.</given-names></string-name> <article-title hwp:id="article-title-6">Shwachman-Diamond syndrome: An inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment</article-title>. <source hwp:id="source-5">Blood</source> <volume>94</volume>, <fpage>3048</fpage>–<lpage>3054</lpage> (<year>1999</year>).</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1 xref-ref-6-2"><label>6</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Hashmi S. K."><surname>Hashmi</surname>, <given-names>S. K.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-7">Comparative analysis of Shwachman-Diamond syndrome to other inherited bone marrow failure syndromes and genotype-phenotype correlation</article-title>. <source hwp:id="source-6">Clin Genet</source> <volume>79</volume>, <fpage>448</fpage>-<lpage>458</lpage>, doi:<pub-id pub-id-type="doi">10.1111/j.1399-0004.2010.01468.x</pub-id> (<year>2011</year>).</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2 xref-ref-7-3 xref-ref-7-4"><label>7</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Weis F."><surname>Weis</surname>, <given-names>F.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-8">Mechanism of eIF6 release from the nascent 60S ribosomal subunit</article-title>. <source hwp:id="source-7">Nat Struct Mol Biol</source> <volume>22</volume>, <fpage>914</fpage>-<lpage>919</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nsmb.3112</pub-id> (<year>2015</year>).</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><label>8</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Menne T. F."><surname>Menne</surname>, <given-names>T. F.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-9">The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast</article-title>. <source hwp:id="source-8">Nat Genet</source> <volume>39</volume>, <fpage>486</fpage>-<lpage>495</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ng1994</pub-id> (<year>2007</year>).</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Narla A."><surname>Narla</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Ebert B. L."><surname>Ebert</surname>, <given-names>B. L.</given-names></string-name> <article-title hwp:id="article-title-10">Ribosomopathies: human disorders of ribosome dysfunction</article-title>. <source hwp:id="source-9">Blood</source> <volume>115</volume>, <fpage>3196</fpage>-<lpage>3205</lpage>, doi:<pub-id pub-id-type="doi">10.1182/blood-2009-10-178129</pub-id> (<year>2010</year>).</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2"><label>10</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Tan Q. K."><surname>Tan</surname>, <given-names>Q. K.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-11">Further evidence for the involvement of EFL1 in a Shwachman-Diamond-like syndrome and expansion of the phenotypic features</article-title>. <source hwp:id="source-10">Cold Spring Harb Mol Case Stud</source> <volume>4</volume>, doi:<pub-id pub-id-type="doi">10.1101/mcs.a003046</pub-id> (<year>2018</year>).</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Stepensky P."><surname>Stepensky</surname>, <given-names>P.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-12">Mutations in EFL1, an SBDS partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in aShwachman-Diamond like syndrome</article-title>. <source hwp:id="source-11">J Med Genet</source> <volume>54</volume>, <fpage>558</fpage>-<lpage>566</lpage>, doi:<pub-id pub-id-type="doi">10.1136/jmedgenet-2016-104366</pub-id> (<year>2017</year>).</citation></ref><ref id="c12" hwp:id="ref-12"><label>12</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Tummala H."><surname>Tummala</surname>, <given-names>H.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-13">DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation</article-title>. <source hwp:id="source-12">Am J Hum Genet</source> <volume>99</volume>, <fpage>115</fpage>-<lpage>124</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.05.002</pub-id> (<year>2016</year>).</citation></ref><ref id="c13" hwp:id="ref-13"><label>13</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Dhanraj S."><surname>Dhanraj</surname>, <given-names>S.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-14">Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome</article-title>. <source hwp:id="source-13">Blood</source> <volume>129</volume>, <fpage>1557</fpage>-<lpage>1562</lpage>, doi:<pub-id pub-id-type="doi">10.1182/blood-2016-08-735431</pub-id> (<year>2017</year>).</citation></ref><ref id="c14" hwp:id="ref-14"><label>14</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Carapito R."><surname>Carapito</surname>, <given-names>R.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-15">Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features</article-title>. <source hwp:id="source-14">J Clin Invest</source> <volume>127</volume>, <fpage>4090</fpage>-<lpage>4103</lpage>, doi:<pub-id pub-id-type="doi">10.1172/JCI92876</pub-id> (<year>2017</year>).</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1 xref-ref-15-2 xref-ref-15-3 xref-ref-15-4 xref-ref-15-5"><label>15</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Tan S."><surname>Tan</surname>, <given-names>S.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-16">EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome</article-title>. <source hwp:id="source-15">Blood</source> <volume>134</volume>, <fpage>277</fpage>-<lpage>290</lpage>, doi:<pub-id pub-id-type="doi">10.1182/blood.2018893404</pub-id> (<year>2019</year>).</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1 xref-ref-16-2"><label>16</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Finch A. J."><surname>Finch</surname>, <given-names>A. J.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-17">Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome</article-title>. <source hwp:id="source-16">Genes Dev</source> <volume>25</volume>, <fpage>917</fpage>-<lpage>929</lpage>, doi:<pub-id pub-id-type="doi">10.1101/gad.623011</pub-id> (<year>2011</year>).</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Chase A."><surname>Chase</surname>, <given-names>A.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-18">PRR14L mutations are associated with chromosome acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia</article-title>. <source hwp:id="source-17">Leukemia</source> <volume>33</volume>, <fpage>1184</fpage>-<lpage>1194</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41375-018-0340-5</pub-id> (<year>2019</year>).</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>18</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Dubois V."><surname>Dubois</surname>, <given-names>V.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-19">Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy</article-title>. <source hwp:id="source-18">Leukemia</source> <volume>26</volume>, <fpage>2079</fpage>-<lpage>2085</lpage>, doi:<pub-id pub-id-type="doi">10.1038/leu.2012.68</pub-id> (<year>2012</year>).</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Roberts J. L."><surname>Roberts</surname>, <given-names>J. L.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-20">CD45-deficient severe combined immunodeficiency caused by uniparental disomy</article-title>. <source hwp:id="source-19">Proc Natl Acad Sci U S A</source> <volume>109</volume>, <fpage>10456</fpage>-<lpage>10461</lpage>, doi:<pub-id pub-id-type="doi">10.1073/pnas.1202249109</pub-id> (<year>2012</year>).</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><label>20</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Swensen J. J."><surname>Swensen</surname>, <given-names>J. J.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-21">Sickle cell disease resulting from uniparental disomy in a child who inherited sickle cell trait</article-title>. <source hwp:id="source-20">Blood</source> <volume>116</volume>, <fpage>2822</fpage>-<lpage>2825</lpage>, doi:<pub-id pub-id-type="doi">10.1182/blood-2010-05-284331</pub-id> (<year>2010</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>21</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Lek M."><surname>Lek</surname>, <given-names>M.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-22">Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source hwp:id="source-21">Nature</source> <volume>536</volume>, <fpage>285</fpage>-<lpage>291</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature19057</pub-id> (<year>2016</year>).</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><label>22</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Loh P. R."><surname>Loh</surname>, <given-names>P. R.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-23">Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations</article-title>. <source hwp:id="source-22">Nature</source> <volume>559</volume>, <fpage>350</fpage>-<lpage>355</lpage>, doi:<pub-id pub-id-type="doi">10.1038/s41586-018-0321-x</pub-id> (<year>2018</year>).</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><label>23</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="el-Amraoui A."><surname>el-Amraoui</surname>, <given-names>A.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-24">Human Usher 1B/mouse shaker-1: the retinal phenotype discrepancy explained by the presence/absence of myosin VIIA in the photoreceptor cells</article-title>. <source hwp:id="source-23">Hum Mol Genet</source> <volume>5</volume>, <fpage>1171</fpage>-<lpage>1178</lpage>, doi:<pub-id pub-id-type="doi">10.1093/hmg/5.8.1171</pub-id> (<year>1996</year>).</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><label>24</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Liao B. Y."><surname>Liao</surname>, <given-names>B. Y.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Zhang J."><surname>Zhang</surname>, <given-names>J.</given-names></string-name> <article-title hwp:id="article-title-25">Null mutations in human and mouse orthologs frequently result in different phenotypes</article-title>. <source hwp:id="source-24">Proc Natl Acad Sci U S A</source> <volume>105</volume>, <fpage>6987</fpage>-<lpage>6992</lpage>, doi:<pub-id pub-id-type="doi">10.1073/pnas.0800387105</pub-id> (<year>2008</year>).</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><label>25</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Draptchinskaia N."><surname>Draptchinskaia</surname>, <given-names>N.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-26">The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia</article-title>. <source hwp:id="source-25">Nat Genet</source> <volume>21</volume>, <fpage>169</fpage>-<lpage>175</lpage>, doi:<pub-id pub-id-type="doi">10.1038/5951</pub-id> (<year>1999</year>).</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><label>26</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Khajuria R. K."><surname>Khajuria</surname>, <given-names>R. K.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-27">Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis</article-title>. <source hwp:id="source-26">Cell</source> <volume>173</volume>, <fpage>90</fpage>-<lpage>103 e119</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.cell.2018.02.036</pub-id> (<year>2018</year>).</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1"><label>27</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Danilova N."><surname>Danilova</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sakamoto K. M."><surname>Sakamoto</surname>, <given-names>K. M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Lin S."><surname>Lin</surname>, <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-28">Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family</article-title>. <source hwp:id="source-27">Blood</source> <volume>112</volume>, <fpage>5228</fpage>-<lpage>5237</lpage>, doi:<pub-id pub-id-type="doi">10.1182/blood-2008-01-132290</pub-id> (<year>2008</year>).</citation></ref><ref id="c28" hwp:id="ref-28"><label>28</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="McGowan K. A."><surname>McGowan</surname>, <given-names>K. A.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-29">Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects</article-title>. <source hwp:id="source-28">Nat Genet</source> <volume>40</volume>, <fpage>963</fpage>-<lpage>970</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ng.188</pub-id> (<year>2008</year>).</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><label>29</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Elghetany M. T."><surname>Elghetany</surname>, <given-names>M. T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Alter B. P."><surname>Alter</surname>, <given-names>B. P.</given-names></string-name> <article-title hwp:id="article-title-30">p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia</article-title>. <source hwp:id="source-29">Arch Pathol Lab Med</source> <volume>126</volume>, <fpage>452</fpage>-<lpage>455</lpage>, doi:10.1043/0003-9985(2002)126&lt;0452:PPOIBM&gt;2.0.CO;2 (<year>2002</year>).</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Provost E."><surname>Provost</surname>, <given-names>E.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-31">Ribosomal biogenesis genes play an essential and p53-independent role in zebrafish pancreas development</article-title>. <source hwp:id="source-30">Development</source> <volume>139</volume>, <fpage>3232</fpage>-<lpage>3241</lpage>, doi:<pub-id pub-id-type="doi">10.1242/dev.077107</pub-id> (<year>2012</year>).</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Ludwig L. S."><surname>Ludwig</surname>, <given-names>L. S.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-32">Altered translation of GATA1 in Diamond-Blackfan anemia</article-title>. <source hwp:id="source-31">Nat Med</source> <volume>20</volume>, <fpage>748</fpage>-<lpage>753</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nm.3557</pub-id> (<year>2014</year>).</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Tcherkezian J."><surname>Tcherkezian</surname>, <given-names>J.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-33">Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5’TOP mRNA translation</article-title>. <source hwp:id="source-32">Genes Dev</source> <volume>28</volume>, <fpage>357</fpage>-<lpage>371</lpage>, doi:<pub-id pub-id-type="doi">10.1101/gad.231407.113</pub-id> (<year>2014</year>).</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Fonseca B. D."><surname>Fonseca</surname>, <given-names>B. D.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-34">La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1)</article-title>. <source hwp:id="source-33">J Biol Chem</source> <volume>290</volume>, <fpage>15996</fpage>-<lpage>16020</lpage>, doi:<pub-id pub-id-type="doi">10.1074/jbc.M114.621730</pub-id> (<year>2015</year>).</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1 xref-ref-34-2"><label>34</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Li H."><surname>Li</surname>, <given-names>H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Durbin R."><surname>Durbin</surname>, <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-35">Fast and accurate long-read alignment with Burrows-Wheeler transform</article-title>. <source hwp:id="source-34">Bioinformatics</source> <volume>26</volume>, <fpage>589</fpage>-<lpage>595</lpage>, doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btp698</pub-id> (<year>2010</year>).</citation></ref><ref id="c35" hwp:id="ref-35"><label>35</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Li H."><surname>Li</surname>, <given-names>H.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-36">The Sequence Alignment/Map format and SAMtools</article-title>. <source hwp:id="source-35">Bioinformatics</source> <volume>25</volume>, <fpage>2078</fpage>-<lpage>2079</lpage>, doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id> (<year>2009</year>).</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>36</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Cingolani P."><surname>Cingolani</surname>, <given-names>P.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-37">A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3</article-title>. <source hwp:id="source-36">Fly (Austin)</source> <volume>6</volume>, <fpage>80</fpage>-<lpage>92</lpage>, doi:<pub-id pub-id-type="doi">10.4161/fly.19695</pub-id> (<year>2012</year>).</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><label>37</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Humphrey W."><surname>Humphrey</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dalke A."><surname>Dalke</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Schulten K."><surname>Schulten</surname>, <given-names>K.</given-names></string-name> <article-title hwp:id="article-title-38">VMD: visual molecular dynamics</article-title>. <source hwp:id="source-37">J Mol Graph</source> <volume>14</volume>, <fpage>33</fpage>-<lpage>38</lpage>, 27-38, doi:<pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id> (<year>1996</year>).</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>38</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Best R. B."><surname>Best</surname>, <given-names>R. B.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-39">Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles</article-title>. <source hwp:id="source-38">J Chem Theory Comput</source> <volume>8</volume>, <fpage>3257</fpage>-<lpage>3273</lpage>, doi:<pub-id pub-id-type="doi">10.1021/ct300400x</pub-id> (<year>2012</year>).</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39</label><citation publication-type="journal" citation-type="journal" ref:id="483362v3.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Phillips J. C."><surname>Phillips</surname>, <given-names>J. C.</given-names></string-name> <etal>et al..</etal> <article-title hwp:id="article-title-40">Scalable molecular dynamics with NAMD</article-title>. <source hwp:id="source-39">J Comput Chem</source> <volume>26</volume>, <fpage>1781</fpage>-<lpage>1802</lpage>, doi:<pub-id pub-id-type="doi">10.1002/jcc.20289</pub-id> (<year>2005</year>).</citation></ref></ref-list></back></article>
